about projects people publications resources resources visit us visit us search search

Quick Links

Recent Citations

Fibrin drives thromboinflammation and neuropathology in COVID-19. Ryu JK, Yan Z et al. Nature. 2024 Sep 26;633(8031):905–913.

Germline mutations in a G protein identify signaling cross-talk in T cells. Ham H, Jing H et al. Science. 2024 Sep 20;385(6715):eadd8947.

The hepatitis C virus envelope protein complex is a dimer of heterodimers. Augestad EH, Holmboe Olesen C et al. Nature. 2024 Sep 19;633(8030):704–709.

Molecular architecture of coronavirus double-membrane vesicle pore complex. Huang Y, Wang T et al. Nature. 2024 Sep 5;633(8028):224–231.

Binding of steroid substrates reveals the key to the productive transition of the cytochrome P450 OleP. Costanzo A, Fata F et al. Structure. 2024 Sep 5;32(9):1465-1476.e3.

Previously featured citations...

Chimera Search

Google™ Search

News

August 1, 2024

Planned downtime: The Chimera and ChimeraX websites, web services (Blast Protein, Modeller, ...) and cgl.ucsf.edu e-mail will be unavailable August 1, 3-6 pm PDT.

July 16, 2024

Chimera production release 1.18 is now available. See the release notes for details.

June 17-18, 2024

Planned downtime: The Chimera and ChimeraX websites, web services (Blast Protein, Modeller, ...) and cgl.ucsf.edu e-mail will be unavailable June 17-18 PDT.

Previous news...

Upcoming Events

Please note that UCSF Chimera is legacy software that is no longer being developed or supported. Users are strongly encouraged to try UCSF ChimeraX, which is under active development.

UCSF Chimera is a program for the interactive visualization and analysis of molecular structures and related data, including density maps, trajectories, and sequence alignments. It is available free of charge for noncommercial use. Commercial users, please see Chimera commercial licensing.

We encourage Chimera users to try ChimeraX for much better performance with large structures, as well as other major advantages and completely new features in addition to nearly all the capabilities of Chimera (details...).

Chimera is no longer under active development. Chimera development was supported by a grant from the National Institutes of Health (P41-GM103311) that ended in 2018.

Feature Highlight

ambient-only lighting

Simple Line Drawing

A simple, line-drawing-like appearance can be achieved by combining black silhouette edges with flat, ambient-only lighting. The image at left of a small molecule in ball-and-stick style can be generated with a few Chimera commands. The same visual effects can be applied to ribbons and other representations, as shown in Neuraminidase Flowers and other Image Gallery entries.

(More features...)

Gallery Sample

p53 Cancer Mutations

Mutations that inactivate the tumor suppressor p53 are found in over 50% of human cancers, and most of the cancer-associated mutations are within its DNA-binding domain. The image shows a tetramer of the p53 DNA-binding domain complexed with DNA (Protein Data Bank entry 2ac0). The tetramer subunits are shown as light blue, green, orange, and yellow ribbons, with red spheres marking several major "hot spots" of mutation. The DNA is shown in purple and blue. (More samples...)


About RBVI | Projects | People | Publications | Resources | Visit Us

Copyright 2018 Regents of the University of California. All rights reserved.